Attached files
| file | filename |
|---|---|
| 10-K - ECHO THERAPEUTICS 10-K 12-31-2010 - Echo Therapeutics, Inc. | form10k.htm |
| EX-23 - EXHIBIT 23 - Echo Therapeutics, Inc. | ex23.htm |
| EX-21 - EXHIBIT 21 - Echo Therapeutics, Inc. | ex21.htm |
| EX-32.1 - EXHIBIT 32.1 - Echo Therapeutics, Inc. | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - Echo Therapeutics, Inc. | ex31_1.htm |
| EX-31.2 - EXHIBT 31.2 - Echo Therapeutics, Inc. | ex31_2.htm |
| EX-10.43 - EXHIBIT 10.43 - Echo Therapeutics, Inc. | ex10_43.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Echo Therapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Harry G. Mitchell, Chief Operating Officer, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Harry G. Mitchell
|
|
|
Harry G. Mitchell
|
|
|
Chief Operating Officer, Chief Financial Officer and
|
|
|
Treasurer
|
|
|
March 18, 2011
|